Novo Nordisk and Catalent deal: net positive or negative for industry?
Novo Nordisk recently acquired three manufacturing facilities from contract development and manufacturing organization Catalent, in a bold move that has sparked a great deal of debate and some backlash.
Source: biopharma-reporter.com